Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
Rojda Ipek, Edyta Schaefer, Manuela Neuenschwander et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis examined prognostic factors for mortality in individuals with diabetes following ST-elevation myocardial infarction (STEMI). It included 37 studies, revealing that non-standard modifiable risk factors, such as age and chronic kidney disease, significantly correlate with mortality. Notably, traditional risk factors did not show increased mortality risk once diabetes was established.
Key findings
- Mortality in diabetic STEMI patients was linked to non-SMuRFs like age and chronic kidney disease.
- Acute cardiac dysfunction, including Killip class III-IV, was associated with higher mortality.
- Diabetes-specific factors, such as glycemic control, correlated with increased mortality risk.
- Traditional SMuRFs did not show an increased mortality risk in established diabetes.
Why it matters
Understanding the specific prognostic factors for mortality in diabetic patients post-STEMI can guide clinicians in risk stratification and inform tailored therapeutic strategies, emphasizing the need for acute management and optimized glycemic control.
What to keep in mind
Of the included studies, 25 had a high risk of bias, which may affect the reliability of the findings.